Laboratory News and Research

RSS

New methods may help identify early signs of Alzheimer's disease: Study

Abnormal brain images combined with examination of the composition of the fluid that surrounds the spine may offer the earliest signs identifying healthy older adults at risk of developing Alzheimer's disease, well before cognitive problems emerge, a study by researchers at UC Davis has found.

12 Jul 2010

Survival rates for people diagnosed with once-deadly cancer increase: Cancer Research UK

People diagnosed with breast, bowel and ovarian cancers and non-Hodgkin's lymphoma are today twice as likely to survive for at least 10 years as those diagnosed in the early 1970s according to new figures1 released by Cancer Research UK.

12 Jul 2010

Hot temperature extremes could become frequent events in the U.S. by 2039: GRL study

Exceptionally long heat waves and other hot events could become commonplace in the United States in the next 30 years, according to a new study by Stanford University climate scientists.

9 Jul 2010

UMMC to partner with Mayo Clinic to discover new therapies, train new medical scientists

The University of Mississippi Medical Center will partner with the renowned Mayo Clinic on a series of initiatives intended to convert laboratory discoveries into new therapies and train a new generation of medical scientists.

9 Jul 2010

OPMEDIC GROUP third-quarter revenue up 9% to $3.899 million

OPMEDIC GROUP Inc., a healthcare-related company in fertility, laboratories and surgeries providing services and facilities to patients and surgeons, is pleased to announce financial results for the third quarter ended May 31, 2010.

9 Jul 2010

EPO grants Brookhaven patent for use of vigabatrin in prevention of addiction to opioids

Catalyst Pharmaceutical Partners, Inc. today announced that the European Patent Office (EPO) granted to Brookhaven Science Associates/Brookhaven National Laboratory (Brookhaven) a European patent for the use of vigabatrin for the prevention of addiction to opioids (e.g., oxycodone, hydrocodone) used in pain management.

9 Jul 2010

NIAID announces $14M in first-year funding to establish 10 new malaria research centers

In an effort to accelerate the control of malaria and help eliminate it worldwide, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, today announced approximately $14 million in first-year funding to establish 10 new malaria research centers around the world.

9 Jul 2010

WHO report examines donors response to developing countries during H1N1 pandemic

CIDRAP News examines a recently-released WHO report on how donor countries and organizations have responded to the needs of developing countries during the H1N1 (swine flu) pandemic. In September, the WHO estimated the "64 'least-resourced countries' needed a total of $1.48 billion of aid for vaccine, medicines and supplies, laboratory and surveillance services, communications capacity, and other activities to respond to the pandemic," according to the news service.

9 Jul 2010

Thermo Fisher Scientific announces new methods to detect petroleum contamination in oysters and fish

Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its global Food Safety Response Center located in Dreieich, Germany, has developed two new analytical screening methods to detect petroleum contamination in oysters and fish, specifically hydrocarbons and poly-aromatic hydrocarbons (PAHs), resulting from the oil spill in the Gulf of Mexico.

From Thermo Fisher Scientific Inc. 9 Jul 2010

Researchers report how mature red blood cells form

We take our blood for granted, but its creation requires a complicated series of steps, starting with the formation of blood stem cells during early embryonic development, followed by progressive differentiation into the progenitors of red cells, white cells and platelets, and ultimately the full set of blood cells.

9 Jul 2010

Sysmex announces three-year, dual source urinalysis contract agreement with Amerinet

Sysmex, a global leader in medical diagnostic testing equipment and information systems technology, today announced a three-year, dual source urinalysis contract agreement with Amerinet. Amerinet members have immediate purchasing/leasing access to Sysmex automated urine particle analyzers, reagents, controls, and service.

From Sysmex America, Inc. 9 Jul 2010

Researcher uses biopharmaceutical proteases to develop novel therapy for Alzheimer's disease

A University of Oklahoma researcher is developing a novel therapy for Alzheimer's disease using "biopharmaceutical proteases" to attack the toxic plaque that builds up in the brain of an Alzheimer's patient-an approach that he predicts will be lower in cost and higher in effectiveness than current therapies.

9 Jul 2010

Research finding uncovers alternative treatments for people with hereditary colorectal cancer

By solving the three-dimensional structure of a protein involved in repairing DNA errors, a group of McMaster University researchers have revealed new avenues to develop assessment tools and alternative treatments for people living with hereditary colorectal cancers.

9 Jul 2010

Jasmine can be used instead of sleeping pills or mood enhancers: Study

Instead of a sleeping pill or a mood enhancer, a nose full of jasmine from Gardenia jasminoides could also help: in collaboration with Dr. Olga Sergeeva and Prof. Helmut Hass from the Heinrich Heine University in Düsseldorf, researchers from Bochum led by Prof. Dr. Dr. Dr. Hanns Hatt have discovered that the two fragrances Vertacetal-coeur (VC) and the chemical variation (PI24513) have the same molecular mechanism of action and are as strong as the commonly prescribed barbiturates or propofol.

9 Jul 2010

Biomagnetics, LANL collaborate to develop device for tuberculosis diagnosis

Biomagnetics Diagnostics Corp., a developer of revolutionary technology for diagnostic systems for HIV, hepatitis, tuberculosis and malaria detection, today announced the signing of an agreement with Los Alamos National Security, LLC where Los Alamos National Laboratory's scientific and engineering staffs will attempt to identify new potential human tuberculosis biomarkers and will develop a validated assay to detect human tuberculosis using a currently known biomarker to be used in combination with the waveguide-based optical biosensor platform.

9 Jul 2010

CompuMed secures extended contracts with Oklahoma and Arizona's departments of corrections

CompuMed, Inc., a medical informatics and telemedicine services company, has secured extended contracts to provide its signature CardioGram™ electrocardiogram (ECG) remote interpretation systems and over-read services for the Oklahoma Department of Corrections (OKDOC) and Arizona Department of Corrections (ADC) at selected facilities throughout both states. The OKDOC rents 21 CardioGram systems, and the ADC owns 45 CardioGram systems.

8 Jul 2010

Calithera Biosciences completes Series A financing totaling $40M

Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.

8 Jul 2010

Advanced Life Sciences announces positive results from preclinical studies of Restanza IV

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced positive results from preclinical toxicology and pharmacokinetic studies of an intravenous (IV) formulation of its novel antibiotic, Restanza™ that support its use in a hospital setting.

8 Jul 2010

SIR and 41 international societies issue first global statement defining interventional radiology

The Society of Interventional Radiology, with the support of 41 international societies representing 10,000 interventional radiology doctors, has issued the first global statement defining interventional radiology-one designed to benefit medical treatment for individuals. The statement addresses the evolution, impact and future direction of this minimally invasive specialty, emphasizing the worldwide availability of this specialized medical care.

8 Jul 2010

Vitamin D receptor emerges as key player amid gut bacteria, scientists find

Within the human digestive tract is a teeming mass of hundreds of types of bacteria, a potpourri of microbes numbering in the trillions that help us digest food and keep bad bacteria in check.

8 Jul 2010

Laboratory News and Research

New methods may help identify early signs of Alzheimer's disease: Study

Survival rates for people diagnosed with once-deadly cancer increase: Cancer Research UK

Hot temperature extremes could become frequent events in the U.S. by 2039: GRL study

UMMC to partner with Mayo Clinic to discover new therapies, train new medical scientists

OPMEDIC GROUP third-quarter revenue up 9% to $3.899 million

EPO grants Brookhaven patent for use of vigabatrin in prevention of addiction to opioids

NIAID announces $14M in first-year funding to establish 10 new malaria research centers

WHO report examines donors response to developing countries during H1N1 pandemic

Thermo Fisher Scientific announces new methods to detect petroleum contamination in oysters and fish

Researchers report how mature red blood cells form

Sysmex announces three-year, dual source urinalysis contract agreement with Amerinet

Researcher uses biopharmaceutical proteases to develop novel therapy for Alzheimer's disease

Research finding uncovers alternative treatments for people with hereditary colorectal cancer

Jasmine can be used instead of sleeping pills or mood enhancers: Study

Biomagnetics, LANL collaborate to develop device for tuberculosis diagnosis

CompuMed secures extended contracts with Oklahoma and Arizona's departments of corrections

Calithera Biosciences completes Series A financing totaling $40M

Advanced Life Sciences announces positive results from preclinical studies of Restanza IV

SIR and 41 international societies issue first global statement defining interventional radiology

Vitamin D receptor emerges as key player amid gut bacteria, scientists find

Pittcon 2024 - Advancing Science on the West Coast eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo